Maslov, Mikhail Y <br/><br/>
Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  02 2019 
 - H289-H297 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1539 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00579.2018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminobutyrates--pharmacology<br/>Angiotensin Receptor Antagonists--pharmacology<br/>Animals<br/>Biphenyl Compounds<br/>Drug Combinations<br/>Drug Synergism<br/>Exercise Tolerance<br/>Fibrosis<br/>Heart--drug effects<br/>Heart Failure--drug therapy<br/>Hemodynamics<br/>Male<br/>Myocardial Contraction<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tetrazoles--pharmacology<br/>Valsartan--pharmacology